Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease

Edward J. Goetzl; Erin L. Abner; Gregory A. Jicha; Dimitrios Kapogiannis; Janice B. Schwartz

doi:10.1096/fj.201700731R

Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease

Edward J. Goetzl
, Erin L. Abner
, Gregory A. Jicha
, Dimitrios Kapogiannis
, Janice B. Schwartz

Producción científica: Article › revisión exhaustiva

193 Citas (Scopus)

Resumen

Interactions of the presynaptic proteins, neuronal pentraxin 2 (NPTX2) and neurexin 2a (NRXN2a), with their respective postsynaptic functional partners, GluA4-containing glutamate (AMPA4) receptor and neuroligin 1 (NLGN1), enhance excitatory synaptic activity in some areas of the hippocampus and cerebral cortex. As early damage of such excitatory circuits in the brain tissues of participantswithAlzheimer's disease (AD) correlateswith cognitive losses, plasmaneuron-derived exosome (NDE) levels of these 2 pairs of specialized synaptic proteins were quantified to assess their biomarker characteristics. TheNDE contents of all 4 proteinswere decreased significantly inADdementia (n=46), anddiminished levels ofAMPA4andNLGN1 correlatedwiththe extent of cognitive loss. In a preclinical period, 6-11 yr before the onset of dementia, theNDE levels of all butNPTX2were significantly lower than those ofmatched controls, and levels of all proteins declined significantly with the development of dementia. Reductions inNDE levels of these specialized excitatory synaptic proteinsmay therefore be indicative of the extent of cognitive loss and may reflect progression of the severity of AD.-Goetzl, E. J., Abner, E. L., Jicha, G. A., Kapogiannis, D., Schwartz, J. B. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease. FASEB J. 32, 888-893 (2018). www.fasebj.org.

Idioma original	English
Páginas (desde-hasta)	888-893
Número de páginas	6
Publicación	FASEB Journal
Volumen	32
N.º	2
DOI	https://doi.org/10.1096/fj.201700731R
Estado	Published - feb 2018

Nota bibliográfica

Publisher Copyright:
© FASEB.

Financiación

The authors thank Judith H. Goetzl (Jewish Home of San Francisco) for expert preparation of the illustrations. This work was supported by a grant from the Biomarkers Across Neurodegenerative Diseases 2 (BAND2) program of the Michael J. Fox Foundation for Parkinson’s Research, the Alzheimer’s Association, Alzheimer’s Research United Kingdom, and the Weston Brain Institute (to E.J.G.); and by the U.S. National Institutes of Health (NIH) National Institute on Aging (NIA) (Grant P30028383; to G.A.J.). D.K. was supported by the Intramural Research Program of the NIH NIA. E.J.G. has filed an application with the U.S. Patent Office for the platform and methodologies described in this report. The remaining authors declare no conflicts of interest.

Financiadores	Número del financiador
Alzheimer’s Research United Kingdom
ARUK Biomarkers Across Neurodegenerative Diseases
NIA/NIH
National Institutes of Health (NIH)
National Institute on Aging	P30AG028383, P30028383
National Institute on Aging
Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment
Weston Brain Institute

ASJC Scopus subject areas

Biotechnology
Biochemistry
Molecular Biology
Genetics

Acceder al documento

10.1096/fj.201700731R

Otros archivos y enlaces

Citar esto

@article{a724d0b055d5499f8983b07e922e6623,

title = "Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease",

abstract = "Interactions of the presynaptic proteins, neuronal pentraxin 2 (NPTX2) and neurexin 2a (NRXN2a), with their respective postsynaptic functional partners, GluA4-containing glutamate (AMPA4) receptor and neuroligin 1 (NLGN1), enhance excitatory synaptic activity in some areas of the hippocampus and cerebral cortex. As early damage of such excitatory circuits in the brain tissues of participantswithAlzheimer's disease (AD) correlateswith cognitive losses, plasmaneuron-derived exosome (NDE) levels of these 2 pairs of specialized synaptic proteins were quantified to assess their biomarker characteristics. TheNDE contents of all 4 proteinswere decreased significantly inADdementia (n=46), anddiminished levels ofAMPA4andNLGN1 correlatedwiththe extent of cognitive loss. In a preclinical period, 6-11 yr before the onset of dementia, theNDE levels of all butNPTX2were significantly lower than those ofmatched controls, and levels of all proteins declined significantly with the development of dementia. Reductions inNDE levels of these specialized excitatory synaptic proteinsmay therefore be indicative of the extent of cognitive loss and may reflect progression of the severity of AD.-Goetzl, E. J., Abner, E. L., Jicha, G. A., Kapogiannis, D., Schwartz, J. B. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease. FASEB J. 32, 888-893 (2018). www.fasebj.org.",

keywords = "Biomarkers, Dementia, Neurodegeneration",

author = "Goetzl, \{Edward J.\} and Abner, \{Erin L.\} and Jicha, \{Gregory A.\} and Dimitrios Kapogiannis and Schwartz, \{Janice B.\}",

note = "Publisher Copyright: {\textcopyright} FASEB.",

year = "2018",

month = feb,

doi = "10.1096/fj.201700731R",

language = "English",

volume = "32",

pages = "888--893",

number = "2",

}

TY - JOUR

T1 - Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease

AU - Goetzl, Edward J.

AU - Abner, Erin L.

AU - Jicha, Gregory A.

AU - Kapogiannis, Dimitrios

AU - Schwartz, Janice B.

N1 - Publisher Copyright: © FASEB.

PY - 2018/2

Y1 - 2018/2

N2 - Interactions of the presynaptic proteins, neuronal pentraxin 2 (NPTX2) and neurexin 2a (NRXN2a), with their respective postsynaptic functional partners, GluA4-containing glutamate (AMPA4) receptor and neuroligin 1 (NLGN1), enhance excitatory synaptic activity in some areas of the hippocampus and cerebral cortex. As early damage of such excitatory circuits in the brain tissues of participantswithAlzheimer's disease (AD) correlateswith cognitive losses, plasmaneuron-derived exosome (NDE) levels of these 2 pairs of specialized synaptic proteins were quantified to assess their biomarker characteristics. TheNDE contents of all 4 proteinswere decreased significantly inADdementia (n=46), anddiminished levels ofAMPA4andNLGN1 correlatedwiththe extent of cognitive loss. In a preclinical period, 6-11 yr before the onset of dementia, theNDE levels of all butNPTX2were significantly lower than those ofmatched controls, and levels of all proteins declined significantly with the development of dementia. Reductions inNDE levels of these specialized excitatory synaptic proteinsmay therefore be indicative of the extent of cognitive loss and may reflect progression of the severity of AD.-Goetzl, E. J., Abner, E. L., Jicha, G. A., Kapogiannis, D., Schwartz, J. B. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease. FASEB J. 32, 888-893 (2018). www.fasebj.org.

AB - Interactions of the presynaptic proteins, neuronal pentraxin 2 (NPTX2) and neurexin 2a (NRXN2a), with their respective postsynaptic functional partners, GluA4-containing glutamate (AMPA4) receptor and neuroligin 1 (NLGN1), enhance excitatory synaptic activity in some areas of the hippocampus and cerebral cortex. As early damage of such excitatory circuits in the brain tissues of participantswithAlzheimer's disease (AD) correlateswith cognitive losses, plasmaneuron-derived exosome (NDE) levels of these 2 pairs of specialized synaptic proteins were quantified to assess their biomarker characteristics. TheNDE contents of all 4 proteinswere decreased significantly inADdementia (n=46), anddiminished levels ofAMPA4andNLGN1 correlatedwiththe extent of cognitive loss. In a preclinical period, 6-11 yr before the onset of dementia, theNDE levels of all butNPTX2were significantly lower than those ofmatched controls, and levels of all proteins declined significantly with the development of dementia. Reductions inNDE levels of these specialized excitatory synaptic proteinsmay therefore be indicative of the extent of cognitive loss and may reflect progression of the severity of AD.-Goetzl, E. J., Abner, E. L., Jicha, G. A., Kapogiannis, D., Schwartz, J. B. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease. FASEB J. 32, 888-893 (2018). www.fasebj.org.

KW - Biomarkers

KW - Dementia

KW - Neurodegeneration

UR - https://www.scopus.com/pages/publications/85041683153

UR - https://www.scopus.com/pages/publications/85041683153#tab=citedBy

U2 - 10.1096/fj.201700731R

DO - 10.1096/fj.201700731R

M3 - Article

C2 - 29025866

AN - SCOPUS:85041683153

SN - 0892-6638

VL - 32

SP - 888

EP - 893

JO - FASEB Journal

JF - FASEB Journal

IS - 2

ER -

Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease

Resumen

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto